Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SERA PROGNOSTICS, INC. Director's Dealing 2021

Jul 21, 2021

34084_dirs_2021-07-21_0705eeb9-72c4-477f-ace2-4068d5c546e7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SERA PROGNOSTICS, INC. (SERA)
CIK: 0001534969
Period of Report: 2021-07-19

Reporting Person: Blue Ox Healthcare Partners, LLC (10% Owner)
Reporting Person: Blue Ox Healthcare Partners SP, LLC (10% Owner)
Reporting Person: BXHCP SP II, LLC (10% Owner)
Reporting Person: BXHCP SP III, LLC (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-07-19 Class A Common Stock C 1515595 Acquired 1515595 Indirect
2021-07-19 Class A Common Stock C 1075047 Acquired 1075047 Indirect
2021-07-19 Class A Common Stock C 1204508 Acquired 1204508 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-07-19 Series D Convertible Preferred Stock $ C 1515595 Disposed Class A Common Stock (1515595) Indirect
2021-07-19 Series D Convertible Preferred Stock $ C 1075047 Disposed Class A Common Stock (1075047) Indirect
2021-07-19 Series E Convertible Preferred Stock $ C 1204508 Disposed Class A Common Stock (1204508) Indirect

Footnotes

F1: Represents shares of Series D Convertible Preferred Stock were automatically converted into Class A Common Stock in connection with the closing of the Issuer's initial public offering. The Series D Convertible Preferred Stock had no expiration date.

F2: Represents shares of Series E Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date.

F3: Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares.